Le agradecemos a Marc Rodwin la interesante información que nos remite a la atención de los lectores de nogracias sobre el reciente simposium «Política farmacéutica y corrupción institucional.»
The symposium Institutional Corruption and Pharmaceutical Policy will be published in the forthcoming issue of the Journal of Law, Medicine & Ethics, 2013: Vol. 14 (3).Advanced copies of the 16 symposium articles are now available through SSRN online. http://www.ethics.harvard.edu/
«The goals of pharmaceutical policy and medical practice are often undermined due to institutional corruption — that is, widespread or systemic practices, usually legal, that undermine an institution’s objectives or integrity. The pharmaceutical industry’s own purposes are often undermined. In addition, pharmaceutical industry funding of election campaigns and lobbying skews the legislative process that sets pharmaceutical policy. Moreover, certain practices have corrupted medical research, the production of medical knowledge, the practice of medicine, drug safety, and the Food and Drug Administration’s oversight of pharmaceutical marketing». I invited a group of scholars to analyze these issues, with each author taking a different look at the sources of corruption, how it occurs and what is corrupted. The articles address five topics: (1) systemic problems, (2) medical research, (3) medical knowledge and practice, (4) marketing, and (5) patient advocacy organizations.» http://papers.ssrn.com/sol3/
Muchas gracias a Marc Rodwin